title: Fulminant course of angiosarcoma of the scalp on multimodal therapy with paclitaxel, bevacizumab, and radiation.
authors.affiliation: Department of Dermatology, University Hospital, Jena, Germany.
authors.forename: Susanne
authors.initials: S
authors.lastname: Darr-Foit
authors.affiliation: Department of Dermatology, University Hospital, Jena, Germany.
authors.forename: Steven
authors.initials: S
authors.lastname: Goetze
authors.affiliation: Department of Dermatology, University Hospital, Jena, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Elsner
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000068258:Bevacizumab / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005153:Facial Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use; D012535:Scalp
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000068258:Bevacizumab; D017239:Paclitaxel